Medindia
Medindia LOGIN REGISTER
Advertisement

Reportlinker Adds India Pharmaceutical Regulatory Report 2010 + Appendix

Wednesday, February 17, 2010 Press Release
Advertisement


NEW YORK, Feb. 16 Reportlinker.com announces that a new market research report is available in its catalogue:

India Pharmaceutical Regulatory Report 2010 + Appendix
Advertisement

http://www.reportlinker.com/p0177885/India-Pharmaceutical-Regulatory-Report-2010-+-Appendix.html

The India Pharmaceutical Regulatory Report comprehensively covers all aspects of pharmaceutical regulations in India. It includes overviews of the laws and procedures on registration, manufacturing, distribution, price control, marketing, research and development, and intellectual property protection. It also includes an overview of the Indian pharmaceutical market and foreign involvement in the market up to 2009. How suited the country is to different kinds of market entry - such as manufacturing, sales, or research - is discussed in relation to the regulatory and market environment. As India's pharmaceutical market is poised for steady growth, reaching an estimated $11 billion in 2008, understanding of Indian regulatory issues is crucial for success there.
Advertisement

I. Indian Economy Overview

II. Overview of Healthcare System

A. History

B. Healthcare Providers

C. Healthcare Spending

D. Conclusion

III. Pharmaceutical Industry

A. Market Profile

B. Industry Profile

C. Conclusion

IV. Regulatory Overview

A. Governing Legislation

B. Agencies

V. Drug Registration and Import

A. Overview

B. New Drug Registration

C. Import Registration

D. Import License

E. Adverse Event Reporting

VI. Manufacturing

A. Overview

B. Licensing

C. Good Manufacturing Practice

VII. Distribution

A. Overview

B. Licensing

C. Record-Keeping

D. Packaging and Labeling

E. Price Controls

F. Prescription Management

VIII. Clinical Trials and R&D

A. Overview

B. Restrictions on Clinical Trials

C. Global Clinical Trials

D. Licensing and Monitoring

E. Good Laboratory Practice

F. Accreditation of Testing Laboratories

IX. Intellectual Property Protection

A. History

B. Patent Applications

C. Remaining Restrictions

X. Drug Advertising

XI. Conclusion XII. Appendices:

Procedural Flowcharts

I. Importing drugs

II. Manufacturing drugs

Official Forms

III. Summary

IV. Drug registration

V. New drug

VI. Manufacturing license

VII. Import license

VIII. Wholesale license

Schedule Y Excerpts

IX. Study report format

X. Animal toxicology

XI. Animal pharmacology

XII. Informed consent form

XIII. Adverse event report form

Drug Lists

XIV. Schedules C and C(I)

XV. Schedule G

XVI. Schedule H

XVII. Schedule K

XVIII. Schedules P and P(I)

XIX. Schedule X

XX. Drugs listed in Narcotic Drugs and Psychotropic Substances Act

XXI. Drugs subject to price control

XXII. Drug Quality Standards

XXIII. Listing of CROs in India

XXIV. Healthcare

To order this report:

Pharmaceutical Industry: India Pharmaceutical Regulatory Report 2010 + Appendix

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626

SOURCE Reportlinker
Sponsored Post and Backlink Submission


This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close